2. Academic Validation
  3. Galactose-modified small molecule modulator targets RORα to enhance circadian rhythm and alleviate periodontitis-associated alveolar bone loss

Galactose-modified small molecule modulator targets RORα to enhance circadian rhythm and alleviate periodontitis-associated alveolar bone loss

  • Bone Res. 2025 Oct 30;13(1):91. doi: 10.1038/s41413-025-00445-w.
Guangxia Feng # 1 2 3,  Zhiwen Liao # 4,  Yifan Wang # 5 6,  Qingming Tang 1 2 3,  Nayun Li 1 2 3,  Cheng Li 1,  Yuqing Liu 1 2 3,  Renlong Liu 1 2,  Mingjian Cui 4,  Wenjie Fan 1 2 3,  Ying Yin 1 3,  Lingkui Meng 4,  Jing Zeng 4,  Zetao Chen 7,  Guanzheng Luo 8,  Peng Xiang 8,  Qian Wan 9,  Lili Chen 10 11 12 13
Affiliations

Affiliations

  • 1 Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • 2 School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • 3 Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, Hubei, China.
  • 4 Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, Hubei, China.
  • 5 School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [email protected].
  • 6 Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, Hubei, China. [email protected].
  • 7 Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, China.
  • 8 School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
  • 9 Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, Hubei, China. [email protected].
  • 10 Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [email protected].
  • 11 School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [email protected].
  • 12 Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, Hubei, China. [email protected].
  • 13 Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, China. [email protected].
  • # Contributed equally.
PMID: 41168164 DOI: 10.1038/s41413-025-00445-w
Abstract

Circadian rhythm disorders are associated with dysfunction in inflammatory diseases, and targeted regulation of the circadian rhythm could serve as an intervention strategy. RORα/γ, as core components of circadian clock genes, positively modulate the key circadian molecule BMAL1. In this study, Gala-SR, a potent small-molecule compound designed to effectively regulate circadian rhythms, was synthesized through a monosaccharide modification prodrug strategy via a hydrolysable conjugation of galactose onto SR1078, an unique synthetic agonist of RORα/γ. Compared with SR1078, Gala-SR exhibited significantly greater aqueous solubility, cytocompatibility, pharmacokinetic characteristics and efficacy in the targeted activation of RORα. Importantly, Gala-SR ameliorated rhythm disorders by enhancing amplitude of the circadian rhythm both in vitro and in vivo. In circadian rhythm disordered mice with periodontitis, Gala-SR restored local circadian rhythm and mitigated inflammation in periodontal tissue in a circadian clock-dependent manner, and alleviated alveolar bone loss. Our study demonstrates that Gala-SR exhibits great promise in restoration of circadian rhythm and could potentially serve as a targeted therapeutic intervention for treating inflammatory diseases arising from disruptions in circadian rhythm. This work provides a feasible paradigm for the development and translational application of small molecule modulators targeting circadian rhythms.

Figures
Products